| Identification | Back Directory | [Name]
1H-IMidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4) | [CAS]
1009119-83-8 | [Synonyms]
HCV-IN-29
-[1,1&rsquo
-Biphenyl]-4,4&rsquo
Daclatasvir Intermediate-3
Daclatasvir intermediate-5
Daclatasvir Intermediates 5
Daclatasvir intermediate 03
Daclatasvir Intermediates Ⅲ
Dacaltasvir Intermediate 03
Daclatasvir intermediate III
Daclatasvir Impurity 10 tetra-HCl
Dakatavir hydrochloride impurity 3
-diylbis[2-(2S)-2-pyrrolidinyl-1H-imidazole]Hydrochloride
4,4'-Bis(2-((s)-pyrrolidin-2-yl)-1h-imidazol-5-yl)-1,1'-biphenyl 4hcl
5,5'-[1,1'-Biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-1H-imidazole] HCl
5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4)
5,5-BIPHENYL-4,4-DIYLBIS{2-[(2S)-PYRROLIDIN-2-YL]-1 H-IMIDAZOLE}TERTAHYDROCHLORIDE
5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl hydrochloride (1:4) (N-1)
4,4'-Bis(2-((S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)-1,1'-biphenyl tetrahydrochloride
5,5'-[1,1'-Biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-1H-imidazole] hydrochloride
1H-IMidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride
5,5'-[1,1'-Biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-1H-imidazole] hydrochloride (1:4)
1H-IMidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4)
2-((S)-pyrrolidin-2-yl)-5-(4'-(2-((S)-pyrrolidin-2-yl)-1H-imidazol-4-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazole hydrochloride | [Molecular Formula]
C26H32Cl4N6 | [MDL Number]
MFCD28404675 | [MOL File]
1009119-83-8.mol | [Molecular Weight]
461.01 |
| Hazard Information | Back Directory | [Uses]
5,5''-[1,1''-Biphenyl]-4,4''-diylbis[2-(2S)-2-pyrrolidinyl-1H-imidazole] Hydrochloride is a derivative of Daclatasvir (D101500), which inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). |
|
|